These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 9626136
1. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid. Segev DL, Saji M, Phillips GS, Westra WH, Takiyama Y, Piantadosi S, Smallridge RC, Nishiyama RH, Udelsman R, Zeiger MA. J Clin Endocrinol Metab; 1998 Jun; 83(6):2036-42. PubMed ID: 9626136 [Abstract] [Full Text] [Related]
2. Polymerase chain reaction-based microsatellite analysis of fine-needle aspirations from Hürthle cell neoplasms. Takiyama Y, Saji M, Clark DP, Phillips GS, Segev DL, Smallridge RC, Westra WH, Udelsman R, Zeiger MA. Thyroid; 1997 Dec; 7(6):853-7. PubMed ID: 9459628 [Abstract] [Full Text] [Related]
3. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression. Sugishita Y, Kammori M, Yamada O, Yamazaki K, Ito K, Fukumori T, Yoshikawa K, Yamada T. Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933 [Abstract] [Full Text] [Related]
4. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid. Máximo V, Preto A, Crespo A, Rocha AS, Machado JC, Soares P, Sobrinho-Simões M. BMC Cancer; 2004 Mar 25; 4():12. PubMed ID: 15043758 [Abstract] [Full Text] [Related]
5. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene. Farrand K, Delahunt B, Wang XL, McIver B, Hay ID, Goellner JR, Eberhardt NL, Grebe SK. J Clin Endocrinol Metab; 2002 Oct 25; 87(10):4715-21. PubMed ID: 12364463 [Abstract] [Full Text] [Related]
6. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence. Wada N, Duh QY, Miura D, Brunaud L, Wong MG, Clark OH. J Clin Endocrinol Metab; 2002 Oct 25; 87(10):4595-601. PubMed ID: 12364440 [Abstract] [Full Text] [Related]
7. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW. Diagn Cytopathol; 2006 May 25; 34(5):330-4. PubMed ID: 16604553 [Abstract] [Full Text] [Related]
8. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis]. Grineva EN, Goriushkina EV, Malakhova TV, Tsoĭ UA. Vopr Onkol; 2004 May 25; 50(1):41-5. PubMed ID: 15088519 [Abstract] [Full Text] [Related]
9. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. Ward LS, Brenta G, Medvedovic M, Fagin JA. J Clin Endocrinol Metab; 1998 Feb 25; 83(2):525-30. PubMed ID: 9467569 [Abstract] [Full Text] [Related]
10. Molecular analysis of Hurthle cell neoplasms by gene profiling. Finley DJ, Zhu B, Fahey TJ. Surgery; 2004 Dec 25; 136(6):1160-8. PubMed ID: 15657571 [Abstract] [Full Text] [Related]
11. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas. Nascimento MC, Bisi H, Alves VA, Longatto-Filho A, Kanamura CT, Medeiros-Neto G. Endocr Pathol; 2001 Dec 25; 12(3):275-9. PubMed ID: 11740048 [Abstract] [Full Text] [Related]
12. Hürthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy. McKee S, Wu H, Wang X, Cramer H, Lin J, Chen S. Acta Cytol; 2014 Dec 25; 58(3):235-8. PubMed ID: 24819535 [Abstract] [Full Text] [Related]
14. Management of follicular and Hürthle cell neoplasms of the thyroid gland. McHenry CR, Sandoval BA. Surg Oncol Clin N Am; 1998 Oct 25; 7(4):893-910. PubMed ID: 9735140 [Abstract] [Full Text] [Related]
15. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR. Jin L, Lloyd RV, Nassar A, Lappinga PJ, Sebo TJ, Swartz K, Seys AR, Erickson-Johnson MR, Roth CW, Evers BR, Oliveira AM, Zhang J. Diagn Mol Pathol; 2011 Jun 25; 20(2):71-80. PubMed ID: 21532495 [Abstract] [Full Text] [Related]
16. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization. Tallini G, Hsueh A, Liu S, Garcia-Rostan G, Speicher MR, Ward DC. Lab Invest; 1999 May 25; 79(5):547-55. PubMed ID: 10334566 [Abstract] [Full Text] [Related]
17. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm. Covach A, Patel S, Hardin H, Lloyd RV. Endocr Pathol; 2017 Sep 25; 28(3):207-212. PubMed ID: 28660408 [Abstract] [Full Text] [Related]
18. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis. Elliott DD, Pitman MB, Bloom L, Faquin WC. Cancer; 2006 Apr 25; 108(2):102-9. PubMed ID: 16453320 [Abstract] [Full Text] [Related]
19. The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma. Dosen D, Turić M, Smalcelj J, Janusić R, Grgić MP, Separović V. Head Neck; 2003 Jul 25; 25(7):521-8. PubMed ID: 12808654 [Abstract] [Full Text] [Related]
20. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE. Am J Surg Pathol; 2002 Aug 25; 26(8):1016-23. PubMed ID: 12170088 [Abstract] [Full Text] [Related] Page: [Next] [New Search]